Yusuf (YP) Saleeby, MD - Update on COVID, Long COVID and LDN (LDN; low dose naltrexone)

‘Promising Results’ for Low-Dose Naltrexone as Pain Reliever

Pain News Network
15 November 2022
https://www.painnewsnetwork.org/stories/2022/11/15/promising-results-for-low-dose-naltrexone-as-pain-reliever

Low-Dose Naltrexone Promising for pain relief in fibromyalgia and host of chronic conditions

Medical Dialogues
15 November 2022
https://medicaldialogues.in/medicine/news/low-dose-naltrexone-promising-for-pain-relief-in-fibromyalgia-and-host-of-chronic-conditions-102374

Long COVID Is Common and Scary!

The People's Pharmacy
04 October 2022
https://www.peoplespharmacy.com/articles/long-covid-is-common-and-scary

The LDN 3: To Purchase with discounts before 1st September 2022 Go to ldnresearchtrust.org/ldn-book-3 for full details

This was an LDN Radio Show interview in 2022.

Linda Elsegood: Welcome to the LDN Radio Show, brought to you by the LDN Research Trust I'm your host, Linda Elsegood. I have an exciting lineup of guest speakers who are LDN experts in their field. We will be discussing low-dose naltrexone and its many uses in autoimmune diseases, cancers, etc. Thank you for joining us.